A Multicenter, Single-Arm, Open-Label Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Otherwise Healthy Pediatric Patients From Birth to < 1 Year With Influenza-Like Symptoms
Phase of Trial: Phase III
Latest Information Update: 06 Dec 2018
At a glance
- Drugs Baloxavir-marboxil (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Registrational
- Sponsors Roche
- 28 Nov 2018 Status changed from not yet recruiting to recruiting.
- 25 Oct 2018 Planned initiation date changed from 27 Oct 2018 to 13 Dec 2018.
- 06 Sep 2018 New trial record